Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

luteinizing hormone-releasing hormone agonist

(LOO-tih-NY-zing HOR-mone-reh-LEE-sing HOR-mone A-guh-nist)
A substance that keeps the testicles and ovaries from making sex hormones by blocking other hormones that are needed to make them. In men, luteinizing hormone-releasing hormone agonists cause the testicles to stop making testosterone. In women, they cause the ovaries to stop making estrogen and progesterone. Some luteinizing hormone-releasing hormone agonists are used to treat prostate cancer. Also called GnRH agonist, GnRHa, gonadotropin-releasing hormone agonist, and LHRH agonist.
Search NCI's Dictionary of Cancer Terms